Your Location:
Home >
Browse articles >
Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021
Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021
- “Reporting on the latest research in the field of urology, the study presents a comprehensive assessment of the global burden of six common urologic diseases. The research, based on data from the Global Burden of Disease 2021, reveals that BPH and UTI are the leading causes of incidence and prevalence, while prostate cancer tops mortality and DALYs rates. The study also highlights the impact of risk factors such as high BMI and smoking on kidney, bladder, and prostate cancer deaths, underscoring the need for international collaboration to improve disease management.”
- Military Medical Research Vol. 12, Issue 7, Pages: 1007-1022(2025)
DOI: 10.1186/s40779-024-00569-w
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 3 ) Tabs( 3 )
References
Publication Info
Metrics
99
Views
62
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990–2019
National and subnational burden and causes of anemia in China from 1990 to 2023: findings from the Global Burden of Disease Study 2023
Performance of GPT-4 for automated prostate biopsy decision-making based on mpMRI: a multi-center evidence study
Global burden and cross-country inequalities in urinary tumors from 1990 to 2021 and predicted incidence changes to 2046
Salmonella enterica mediated epigenetic promotion of fibrosis is a novel factor in benign prostatic hyperplasia
Related Author
Hao Zi
Shao-Hua He
Xie-Yuan Leng
Xiao-Feng Xu
Hong Weng
Cong Zhu
Lu-Yao Li
Jia-Min Gu
Related Institution
Department of Urology, Zhongnan Hospital of Wuhan University
Precision Medicine Centre, the Second People’s Hospital of Huaihua
the First School of Clinical Medicine, Anhui Medical University
Department of Urology, Xianyang Central Hospital
Department of Urology, the First Affiliated Hospital of Xi’an Jiaotong University

